Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Cypros is granted U.S. patent for CPC-211 dosing regimen

June 28, 1996

Lifarizine shows positive results in efficacy/safety study

June 28, 1996

Suntory describes metabotropic glutamate antagonists

June 28, 1996

RPR reports glutamate antagonists

June 28, 1996

NMDA antagonists synthesized by Hoechst Marion Roussel

June 28, 1996

Takeda seeks German approval for idebenone

June 28, 1996

Ampalex proves effective and safe

June 28, 1996

Protein kinase inhibitors reported by Cephalon

June 28, 1996

FDA approves drug/device combination

June 28, 1996

FDA clears Myotrophin early access program

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...